Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 4985-4993

  Deepe Jr , George S ^a,b   Gibbons, Reta ^a   Woodward, Erin ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HOST RESISTANCE; IMMUNE RESPONSE; INTERFERON PRODUCTION; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, MONOCLONAL; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CYTOKINES; FLOW CYTOMETRY; FREE RADICALS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOPLASMA; HISTOPLASMOSIS; INTERLEUKIN-10; INTERLEUKIN-4; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; NITRIC OXIDE;

EID: 0345425628     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Deepe, G. S., Jr., and W. E. Bullock. 1992. Histoplasmosis: a granulomatous inflammatory response. In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 943.
2. Graybill, J. R. 1988. Histoplasmosis and AIDS. J. Infect. Dis. 158:623.
3. Allendoerfer, R., G. P. Boivin, and G. S. Deepe, Jr. 1997. Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis. 175:905.
4. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ J. Immunol. 155:785.
5. Allendoerfer, R., and G. S. Deepe, Jr. 1997. Intrapulmonary response to Histoplasma capsulatum in γ interferon knockout mice. Infect. Immun. 65:2564.
6. Cain J. A., and G. S. Deepe, Jr. 1998. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. 66:1473.
7. Smith, J. G., D. M. Magee, D. M. Williams, and J. R. Graybill. 1990. Tumor necrosis factor-α plays a role in host defense against Histoplasma capsulatum. J. Infect. Dis. 162:1349.
8. Wu-Hsieh, B. A., G. S. Lee, M. Franco, and F. M. Hofman. 1992. Early activation of splenic macrophages by tumor necrosis factor α is important in determining the outcome of experimental histoplasmosis in mice. Infect. Immun. 60: 4230.
9. Allendoerfer, R., and G. S. Deepe, Jr. 1998. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 160:6072.
10. Zhou, P., G. Miller, and R. A Seder. 1998. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ. J. Immunol. 160:1359.
11. Metcalf, D. 1991. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 254:529.
12. Lieschke, G. J., and A. W. Burgess. 1992. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 327:28.
13. Grabstein, K. H., D. L. Urdal, R. J. Tushinski, D. Y. Mochizuki, V. L. Price, M. A. Cantrell, S. Gillis, and P. J. Conlon. 1986. Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232:506.
14. Reed, S. G., C. F. Nathan, D. L. Pihl, P. Rodricks, K. Shanebeck, P. J. Conlon, and K. H. Grabstein. 1987. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypansoma cruzi and release hydrogen peroxide: comparison with interferon-γ. J. Exp. Med. 166:1734.
15. Fischer, H.-G., S. Frosch, K. Reske, and A. B. Reske-Kunz. 1988. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 141:3882.
16. Newman, S. L., and L. Gootee. 1992. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect. Immun. 60:4593.
17. Allendörfer, R. G. D Brunner, and G. S. Deepe, Jr. 1999. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J. Immunol. 162:7389.
18. + T cells in host defense against Histoplasma capsulatum. Infect. Immun. 56:1685.
19. + T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol. 152:3491.
20. MacMicking, J., Q.-W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323.
21. Hill, A. D., H. Naarma, J. Shou, S. E. Calvano, and J. M. Daly. 1995. Antimicrobial effects of granulocyte-macrophage colony-stimulating factor in protein-energy malnutrition. Arch. Surg. 130:1273.
22. Blau, H., S. Riklis, J. F. Van Iwaarden, F. X. McCormack, and M. Kalina. 1997. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. Am. J. Physiol. 272:L1198.
23. Sarmento, A., and R. Appelberg. 1996. Involvement of reactive oxygen intermediates in tumor necrosis factor α-dependent bacteriostasis of Mycobacterium avium. Infect. Immun. 64:3224.
24. Li, Y., A. Ferrante, A. Poulos, and D. P. Harvey. 1996. Neutrophil oxygen radical generation: synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids. J. Clin. Invest. 97:1605.
25. Billiau, A. 1996. Interferon-γ: biology and role in pathogenesis. Adv. Immunol. 62:61.
26. Bullock, W. E., and S. D. Wright. 1987. Role of adherence-promoting receptors, CR3, LFA-1, and p 150,95 in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med 165:195.
27. Eissenberg, L. G., and W. E. Goldman. 1987. Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect. Immun. 55:29.
28. Basu, S., A. R. Dunn, M. W. Marino, H. Savoia, G. Hodgson, G. J. Lieschke, and J. Cebon. 1997. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 159:1412.
29. Rhoades K. L., S. Cai, S. H. Golub, and J. S. Economou. 1995. Granulocyte-macrophage colony-stimulating factor and interleukin-4 differentially regulate human tumor necrosis factor-α promoter region. Cell. Immunol. 161:125.
30. Munker, R., J. Gasson, M. Ogawa, and H. P. Koeffler. 1986. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 323:79.
31. Lenhoff, S., B. Sallerfors, T. Olofsson. 1998. IL-10 as an autorcine regulator of CSF secretion by monocytes: disparate effects on GM-CSF and G-CSF secretion. Exp. Hematol. 26:299.
32. Ikegami, M., T. Ueda, W. Hull, J. A. Whitsett, R. C. Mulligan, G. Dranoff, and A. H. Jobe. 1996. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am. J. Physiol. 270:L650.